Skip to main content
. 2018 Aug 13;18:135. doi: 10.1186/s12890-018-0678-5

Table 1.

Patients with lung NET, Na

MarketScan PharMetrics
2009 2010 2011 2012 2013 2014 2009 2010 2011 2012 2013 2014
N 435 521 681 796 667 687 419 510 563 598 616 648
Age, year, no. (%)
 18–24 9 (2.1) 6 (1.2) 9 (1.3) 9 (1.1) 7 (1.0) 2 (0.3) 7 (1.7) 5 (1.0) 10 (1.8) 10 (1.7) 7 (1.1) 9 (1.4)
 25–34 16 (3.7) 27 (5.2) 26 (3.8) 37 (4.6) 26 (3.9) 30 (4.4) 29 (6.9) 18 (3.5) 23 (4.1) 19 (3.2) 27 (4.4) 17 (2.6)
 35–44 44 (10.1) 57 (10.9) 67 (9.8) 75 (9.4) 68 (10.2) 79 (11.5) 38 (9.1) 59 (11.6) 46 (8.2) 61 (10.2) 65 (10.6) 60 (9.3)
 45–54 117 (26.9) 152 (29.2) 205 (30.1) 217 (27.3) 182 (27.3) 198 (28.8) 123 (29.4) 136 (26.7) 156 (27.7) 166 (27.8) 165 (26.8) 162 (25.0)
 55–64 249 (57.2) 279 (53.6) 374 (54.9) 458 (57.5) 384 (57.6) 378 (55.0) 222 (53.0) 292 (57.3) 328 (58.3) 342 (57.2) 352 (57.1) 400 (61.7)
Female 260 (59.8) 340 (65.3) 445 (65.3) 515 (64.7) 463 (69.4) 459 (66.8) 258 (61.6) 315 (61.8) 352 (62.5) 392 (65.6) 403 (65.4) 435 (67.1)

a Adult patients (age 18 years or older) with ≥1 inpatient or ≥ 2 outpatient claims for lung NET in a calendar year. Patients may have been identified in multiple calendar years. Continuous enrollment not required